Mankind Pharma (MANKIND)
FAST GROWERFairStock Score: 51/100 — MIXED
Score breakdown: P/E: 0/3 · ROCE: 1/2 · Growth: 2/2 · Dividend: 0/1
Key Financials
| Current Price | ₹2,291.85 |
| Market Cap | ₹92,782.07 Cr |
| P/E Ratio | 49.96 |
| ROCE | 15.98% |
| ROE | 12.41% |
| Dividend Yield | 0.04% |
| Profit Growth | -12.84% |
| Debt/Equity | 0.55 |
| Sales Growth | 20.46% |
| Free Cash Flow | ₹-10,21,100 Cr |
| Promoter Holding | 72.66% |
| 52-Week Range | ₹1,909.7 — ₹2,716.5 |
| Sector | Pharmaceuticals & Biotechnology |
| Book Value | ₹347.2 |
Mankind Pharma trades with a P/E ratio of 49.96, ROCE of 15.98%, ROE of 12.41%, profit growth of -12.84%, debt-to-equity of 0.55. The FairStock Score of 51/100 suggests mixed fundamentals — some metrics look solid while others need improvement.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer